TLSI FY 2024 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

TLSITriSalus Life Sciences, Inc.

$175M

FY 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$29M+59.0% YoY

Gross Profit

$25M86.1% margin

Operating Income

-$36M-122.9% margin

Net Income

-$33M-112.9% margin

EPS (Diluted)

$-1.25

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$41M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$24M

Total Liabilities

$50M

Stockholders' Equity

-$26M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29M	$19M	+59.0%
Gross Profit	$25M	$16M	+59.2%
Operating Income	-$36M	-$54M	+33.6%
Net Income	-$33M	-$59M	+44.0%